Related Experiment Video
Updated: May 1, 2026
09:37
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
14.4K
Portal hypertensive gastropathy and colopathy
Nathalie H Urrunaga1, Don C Rockey2
1Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, 22 S. Greene Street, N3W156, Baltimore, MD 21201, USA.
Clinics in Liver Disease
|April 1, 2014
Summary
Portal hypertensive gastropathy (PHG) and colopathy (PHC) are complications of portal hypertension that can cause significant gastrointestinal bleeding. Diagnosis relies on endoscopy, but varied criteria complicate prevalence assessment and consensus.
Area of Science:
- Gastroenterology
- Hepatology
- Endoscopy
Background:
- Portal hypertensive gastropathy (PHG) and colopathy (PHC) are recognized complications of portal hypertension.
- These conditions pose clinical significance due to potential for insidious or massive gastrointestinal bleeding.
Purpose of the Study:
- To review the diagnostic challenges and therapeutic approaches for PHG and PHC.
- To highlight the need for further research into the natural history, pathogenesis, and treatment of these conditions.
Main Methods:
- Diagnosis of PHG and PHC relies on endoscopic evaluation.
- Therapeutic strategies primarily focus on reducing portal pressure and mucosal blood flow.
Main Results:
- Discrepancies in endoscopic criteria for PHG and PHC lead to difficulties in achieving consensus and result in wide variations in reported prevalence.
- Nonselective beta-blockers are commonly employed for managing acute bleeding episodes.
Conclusions:
- Standardized endoscopic criteria are needed to improve diagnostic consistency and prevalence reporting for PHG and PHC.
- Further research is essential to elucidate the natural history, pathogenesis, and optimal treatment strategies for portal hypertensive gastropathy and colopathy.
Related Concept Videos
01:22Portal Hypertension
50
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
38
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
38
01:17Gastritis-II: Pathophysiology
1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
01:23Gastritis III: Clinical Manifestations and Management
1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
01:24Peptic Ulcer Disease II: Pathophysiology
44
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
44
01:28Peptic Ulcer Disease II: Pathophysiology
3.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K